During the past decade, Charite - UB - CVK - Medizinische Klinik conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study to Evaluate the Efficacy and Safety of BIIB059 (Litifilimab) in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care
According to Clinical.Site data, the most researched conditions in "Charite - UB - CVK - Medizinische Klinik" are
"Gastro-enteropancreatic Neuroendocrine Tumor" (1 trials), "Pyruvate Kinase Deficiency" (1 trials), "Transfusion-dependent Alpha-Thalassemia" (1 trials) and "Transfusion-dependent Beta-Thalassemia" (1 trials). Many other conditions were trialed in "Charite - UB - CVK - Medizinische Klinik" in a lesser frequency.
Most popular intervention types in "Charite - UB - CVK - Medizinische Klinik" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "AG-348" (1 trials), "CAM2029" (1 trials), "Lanreotide ATG" (1 trials), "Mitapivat" (1 trials) and "Octreotide LAR" (1 trials). Other intervention names were less common.
The vast majority of trials in "Charite - UB - CVK - Medizinische Klinik" are
3 trials for "All" genders.
Clinical Trials Status at Charite - UB - CVK - Medizinische Klinik
Currently, there are NaN active trials in "Charite - UB - CVK - Medizinische Klinik".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Charite - UB - CVK - Medizinische Klinik,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Charite - UB - CVK - Medizinische Klinik, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".